TABLE 4.

Comparison of patients prescribed 14-membered ring macrolides

Characteristic	MR patients (n = 8)	MS patients (n = 7)	P
Total febrile days
Median (range)	10.0 (4-19)	6.0 (4-9)	0.152
Mean	10.4	6.6
Febrile days during macrolide administration
Median (range)	3.5 (1-11)	1.0 (1-2)	0.004
Mean	4.9	1.1
Febrile days before macrolide administration
Median (range)	3.0 (1-10)	5.0 (3-8)	0.152
Mean	4.0	5.4
No. of patients with a febrile period exceeding 48 h after macrolide administration (%)	7 (87.5)	1 (14.3)	0.01
No. of patients with a change of prescription after macrolide administration (%)	6 (75.0)	0	0.007